[Experimental study of late effects of the damaging action of doxorubicin on the lymphoid tissue].
It was shown in experiments with CBA/Lac J mice that both a single use of doxorubicin (MID) and its use during a treatment course (1/10 LD50.10) induced impairment of the morphological composition of the central and peripheral lymphoid organs along with changes in the functional activity of separate cell populations of the immune system which persisted over a prolonged period up to 3 months. The course use of the drug resulted in a significant decrease in the proliferative response of the splenocytes to the polyclonal T- and B-cell mitogens in 1 month, which was followed by inhibition of interleukin-2 production. On the contrary, 1 month later, the single administration of the cytostatic induced activation of the LPS-responding cell populations and an increase in production of the growth factor in the culture of T-lymphocytes.
Zapuskalova
O B
OB
Novitskiĭ
V V
VV
Go'ldberg
E D
ED
D000818:Animals; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D004317:Doxorubicin / Q000009:adverse effects*; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced*; D066298:In Vitro Techniques; D008198:Lymph Nodes / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D051379:Mice; D008808:Mice, Inbred CBA; D013154:Spleen / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D013950:Thymus Gland / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D013997:Time Factors
D004317:Doxorubicin
Otdalennye éffekty povrezhdaiushchego deĭstviia doksorubitsina na limfoidnuiu tka'n v éksperimente.